A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LA
Long Form : lung adenocarcinoma
No. Year Title Co-occurring Abbreviation
2019 Apatinib Mesylate in the treatment of advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance -A Multicenter Randomized Trial. AE, AM, DCR, EGFR-TKI, ORR, PFS
2019 Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing. circRNA, DE, GO, KEGG, NSCLC, PWB, RT-PCR
2019 Cross-disease analysis identified novel common genes for both lung adenocarcinoma and lung squamous cell carcinoma. CDK4, EPAS1, LSCC, MLR, SLC2A1
2019 Differentiation of focal organising pneumonia and peripheral adenocarcinoma in solid lung lesions using thin-section CT-based radiomics. AIC, CT, FOP, ROC
2019 Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1. EVs, miRNA, TP53AIP1
2019 MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1. Bmi-1, EMT, IHC, qRT-PCR
2019 MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. qRT-PCR
2019 MiR-218-5p Suppresses the Killing Effect of Natural Killer Cell to Lung Adenocarcinoma by Targeting SHMT1. IFN-gamma, IL-2, miRNAs, NK, qRT-PCR, SHMT1, TNF-alpha
2019 SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma. GATA3, GCDFP15, SOX10, TNBC, TTF-1
10  2019 The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy. PDTC/ATC
11  2018 Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma. AUC, ROC
12  2018 Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma. EMT, lncRNA, RIP, RT-qPCR
13  2018 FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value. DFS
14  2018 Measurement of telomere length in cells from pleural effusion: Asbestos exposure causes telomere shortening in pleural mesothelial cells. EMA, GLUT1, IMP3, MM, NN
15  2018 miR-339-5p inhibits lung adenocarcinoma invasion and migration by directly targeting BCL6. BCL6, miRNAs
16  2018 MiR-608 exerts tumor suppressive function in lung adenocarcinoma by directly targeting MIF. MIF, miRNAs
17  2018 Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma. CFR, CIs, HR, LPHb, NPHb
18  2017 A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis. HCs, miRNAs, qRT-PCR
19  2017 Effects of high-intensity focused ultrasound on cisplatin-resistant human lung adenocarcinoma in vitro and in vivo. HIFU
20  2017 Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement. ALK, FISH, IHC, ISH, TMAs
21  2017 Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma. miR, OS, qRT-PCR
22  2016 IL-17A-producing T cells are associated with the progression of lung adenocarcinoma. HCs, LC
23  2016 PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study. CG, D-Di, HB, HPA, MTS, PPL, RAM, TFa, TG
24  2016 Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer. MAPK, RAF
25  2014 MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1). miRNAs
26  2004 [Analysis of gene expression profile in lung adenocarcinoma, tumor adjacent tissue and fetal lung tissue]. FLT, TAT
27  1995 [A case-control study on the risk factors of lung cancer in Guangdong]. L. S